LIMN
Liminatus Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LIMN fundamentals
Liminatus Pharma (LIMN) released its earnings on Aug 23, 2024: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.07 (YoY -333.33%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.07
-333.33%
Report date
Aug 23, 2024
EPS
Revenue
Revenue & Expenses
Key Indicators
Liminatus Pharma (LIMN) key financial stats and ratios, covering profitability, financial health, and leverage.
Liminatus Pharma (LIMN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Liminatus Pharma (LIMN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Liminatus Pharma (LIMN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Liminatus Pharma (LIMN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Liminatus Pharma (LIMN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Liminatus Pharma do and what are its main business segments?What is the market's earnings forecast for Liminatus Pharma next quarter?What is Liminatus Pharma's gross profit margin?What is Liminatus Pharma's latest dividend and current dividend yield?What guidance did Liminatus Pharma's management provide for the next earnings period?What is the revenue and EPS growth rate for Liminatus Pharma year over year?What were the key takeaways from Liminatus Pharma’s earnings call?What were the key takeaways from Liminatus Pharma's earnings call?
